Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.

Full Abstract

Atomoxetine and OROS methylphenidate were successfully used concomitantly in a 10-year-old boy suffering from attention-deficit/hyperactivity disorder (ADHD) with comorbid bipolar disorder and Tourette syndrome (TS). The child received valproic acid, clonidine, and ziprasidone concurrently. Because possible side effects of pharmacological treatment for one diagnosis may exacerbate a comorbid condition, contingent management strategies, when using polypharmacy, are mandated.

Learn Faster Today Improve your study skills

Author information

Author/s: Jaworowski, Sol (S); Benarroch, Fortu (F); Gross-Tsur, Varda (V);

Affiliation: Department of Liaison Consultation Psychiatry, Shaare Zedek Medical Centre, Jerusalem, Israel 91031. evesol(-atsign-)netvision.net.il

Journal and publication information

Publication Type: Case Reports; Journal Article

Journal: Journal of child and adolescent psychopharmacology (J Child Adolesc Psychopharmacol), published in United States. (Language: eng)

Reference: 2006-Jun; vol 16 (issue 3) : pp 365-70

Dates: Created 2006/06/13; Completed 2006/11/07;

PMID: 16768644, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Adrenergic Uptake Inhibitors - therapeutic use
Attention Deficit Disorder with Hyperactivity - drug therapy; epidemiology
Bipolar Disorder - drug therapy; epidemiology
Central Nervous System Stimulants - therapeutic use
Child
Clonidine - therapeutic use
Comorbidity

Drug Therapy, Combination
Humans
Male
Methylphenidate - therapeutic use
Propylamines - therapeutic use
Tics - drug therapy
Tourette Syndrome - drug therapy; epidemiology

Associated Chemicals: Adrenergic Uptake Inhibitors (0) ; Central Nervous System Stimulants (0) ; Propylamines (0) ; Methylphenidate (113-45-1) ; Clonidine (4205-90-7) ; atomoxetine (83015-26-3)

These are the highest related articles currently in the database:

Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary. 30 Jan 2006
Dopamine transporter genotype influences the physiological response to medication in ADHD. 5 Jun 2006
[Diagnosis and treatment of tics] 19 May 2007
Ritalin is okay for kids with both ADHD and Tourette's syndrome, study says. 20 Mar 2002
Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. 30 Dec 1992
Attention deficit disorder. 29 Sep 1996
Tourette's syndrome: are stimulants safe? 29 Jun 2003
Stimulant-atypical antipsychotic interaction and acute dystonia. 30 May 2005
Trichotillomania and co-morbid psychiatric disorders in a 10-year-old boy. 30 Jan 2007
Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings. 29 Apr 1992

See 100+ related articles.